<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Nature Precedings - john rossi</title>
    <link>http://precedings.nature.com/users/ce34ad71601abbfc0348dd617dbc94f7/</link>
    <description>Documents posted by john rossi</description>
    <dc:publisher>Nature Publishing Group</dc:publisher>
    <dc:language>en</dc:language>
    <prism:publicationName>Nature Precedings</prism:publicationName>
    <image>
      <title>Nature Precedings</title>
      <url>http://precedings.nature.com/images/header_logo.gif</url>
      <link>http://precedings.nature.com</link>
    </image>
    <atom:link type="application/rss+xml" rel="self" href="http://precedings.nature.com/users/ce34ad71601abbfc0348dd617dbc94f7/feed"/>
    <item>
      <title>Novel Cell type-specific aptamer-siRNA delivery system for HIV-1 therapy</title>
      <link>http://dx.doi.org/10.1038/npre.2007.1299.1</link>
      <description>The successful use of small interfering RNAs (siRNAs) for therapeutic purposes requires safe and efficient delivery to specific cells and tissues. Here we demonstrate cell type-specific delivery of anti-HIV siRNAs via fusion to an anti-gp120 aptamer. The envelope glycoprotein is  expressed on the surface of HIV-1 infected cells, allowing binding and interalization of the aptamer-siRNA chimeric molecules. We demonstrate that the anti-gp120 aptamer-siRNA chimera is specifically taken up by cells expressing HIV-1 gp120, and the appended siRNA is processed by Dicer, releasing an anti-tat/rev siRNA which in turn inhibits HIV replication. We show for the first time a dual functioning aptamer-siRNA chimera in which both the aptamer and the siRNA portions have potent anti-HIV activities and that gp120 expressed on the surface of HIV infected cells can be used for aptamer mediated delivery of anti-HIV siRNAs.  </description>
      <guid>http://dx.doi.org/10.1038/npre.2007.1299.1</guid>
      <pubDate>Wed, 14 Nov 2007 20:51:10 UTC</pubDate>
      <dc:title>Novel Cell type-specific aptamer-siRNA delivery system for HIV-1 therapy</dc:title>
      <dc:identifier>doi:10.1038/npre.2007.1299.1</dc:identifier>
      <dc:date>2007-11-14</dc:date>
      <dc:creator>John Rossi</dc:creator>
      <prism:publicationName>Nature Precedings</prism:publicationName>
      <prism:publicationDate>2007-11-14T20:51:10Z</prism:publicationDate>
      <prism:category>Manuscript</prism:category>
      <prism:section>Biotechnology</prism:section>
      <prism:section>Molecular Cell Biology</prism:section>
      <media:thumbnail url="http://precedings.nature.com/documents/1299/version/1/files/npre20071299-1.pdf.thumb.png"/>
      <creativeCommons:license>http://creativecommons.org/licenses/by/2.5/</creativeCommons:license>
    </item>
  </channel>
</rss>
